# PALSONIFY

NDC: 84015-930
Generic name: PALTUSOTINE
Labeler / Manufacturer: Crinetics Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250925

FDA application: NDA219070

## Active ingredients

- PALTUSOTINE HYDROCHLORIDE: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84015-930"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84015-930
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a6d2ce0-a621-4ee7-983c-977cd948ff4d